Prognostic mutations in persons with isolated neutropenia myelodysplastic syndrome

Myelodysplastic syndrome (MDS) is a heterogeneous clonal myeloid neoplasm of ineffective hematopoiesis, dysplasia and an increased risk of progression to acute myeloid leukemia (AML) [1]. Although ...